{"id":"https://openalex.org/W4385441964","doi":"https://doi.org/10.1093/jsxmed/qdad083","title":"A combination of phosphodiesterase type 5 inhibitor and tamoxifen for acute Peyronie\u2019s disease: the first clinical signals","display_name":"A combination of phosphodiesterase type 5 inhibitor and tamoxifen for acute Peyronie\u2019s disease: the first clinical signals","publication_year":2023,"publication_date":"2023-06-07","ids":{"openalex":"https://openalex.org/W4385441964","doi":"https://doi.org/10.1093/jsxmed/qdad083","pmid":"https://pubmed.ncbi.nlm.nih.gov/37524687"},"language":"en","primary_location":{"id":"doi:10.1093/jsxmed/qdad083","doi":"https://doi.org/10.1093/jsxmed/qdad083","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jsxmed/qdad083","pdf_url":null,"source":{"id":"https://openalex.org/S159512450","display_name":"The Journal of Sexual Medicine","issn_l":"1743-6095","issn":["1743-6095","1743-6109"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Sexual Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/Expert_Opinion_A_combination_of_phosphodiesterase_type_5_inhibitor_and_tamoxifen_for_acute_Peyronie_s_disease_the_first_clinical_signals/23770275","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017136849","display_name":"Selim Cellek","orcid":"https://orcid.org/0000-0002-4856-285X","observed_orcids":["https://orcid.org/0000-0002-4856-285X"]},"institutions":[{"id":"https://openalex.org/I51216347","display_name":"Anglia Ruskin University","ror":"https://ror.org/0009t4v78","country_code":"GB","type":"education","lineage":["https://openalex.org/I51216347"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Selim Cellek","raw_affiliation_strings":["Anglia Ruskin University , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","Fibrosis Research Group , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","Fibrosis Research Group, Medical Technology Research Centre, Anglia Ruskin University, Chelmsford CM1 1SQ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anglia Ruskin University , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","institution_ids":["https://openalex.org/I51216347"]},{"raw_affiliation_string":"Fibrosis Research Group , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","institution_ids":[]},{"raw_affiliation_string":"Fibrosis Research Group, Medical Technology Research Centre, Anglia Ruskin University, Chelmsford CM1 1SQ, United Kingdom","institution_ids":["https://openalex.org/I51216347"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000761366","display_name":"Matthew Megson","orcid":"https://orcid.org/0000-0001-9273-3372","observed_orcids":["https://orcid.org/0000-0001-9273-3372"]},"institutions":[{"id":"https://openalex.org/I1289784979","display_name":"University College Hospital","ror":"https://ror.org/00wrevg56","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1289784979","https://openalex.org/I1340918713"]},{"id":"https://openalex.org/I1340918713","display_name":"University College London Hospitals NHS Foundation Trust","ror":"https://ror.org/042fqyp44","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713"]},{"id":"https://openalex.org/I51216347","display_name":"Anglia Ruskin University","ror":"https://ror.org/0009t4v78","country_code":"GB","type":"education","lineage":["https://openalex.org/I51216347"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Matthew Megson","raw_affiliation_strings":["Anglia Ruskin University , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","Fibrosis Research Group , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","Urology Department, University College London Hospital , London W1G 8PH , United Kingdom","Fibrosis Research Group, Medical Technology Research Centre, Anglia Ruskin University, Chelmsford CM1 1SQ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anglia Ruskin University , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","institution_ids":["https://openalex.org/I51216347"]},{"raw_affiliation_string":"Fibrosis Research Group , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","institution_ids":[]},{"raw_affiliation_string":"Urology Department, University College London Hospital , London W1G 8PH , United Kingdom","institution_ids":["https://openalex.org/I1289784979","https://openalex.org/I1340918713"]},{"raw_affiliation_string":"Fibrosis Research Group, Medical Technology Research Centre, Anglia Ruskin University, Chelmsford CM1 1SQ, United Kingdom","institution_ids":["https://openalex.org/I51216347"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045733440","display_name":"Marcus Maximillian Ilg","orcid":"https://orcid.org/0000-0003-0803-0610","observed_orcids":["https://orcid.org/0000-0003-0803-0610"]},"institutions":[{"id":"https://openalex.org/I51216347","display_name":"Anglia Ruskin University","ror":"https://ror.org/0009t4v78","country_code":"GB","type":"education","lineage":["https://openalex.org/I51216347"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Marcus M Ilg","raw_affiliation_strings":["Anglia Ruskin University , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","Fibrosis Research Group , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","Fibrosis Research Group, Medical Technology Research Centre, Anglia Ruskin University, Chelmsford CM1 1SQ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anglia Ruskin University , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","institution_ids":["https://openalex.org/I51216347"]},{"raw_affiliation_string":"Fibrosis Research Group , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","institution_ids":[]},{"raw_affiliation_string":"Fibrosis Research Group, Medical Technology Research Centre, Anglia Ruskin University, Chelmsford CM1 1SQ, United Kingdom","institution_ids":["https://openalex.org/I51216347"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112757274","display_name":"David John Ralph","orcid":"https://orcid.org/0000-0002-4726-1182","observed_orcids":["https://orcid.org/0000-0002-4726-1182","https://orcid.org/0000-0002-5939-7036"]},"institutions":[{"id":"https://openalex.org/I1289784979","display_name":"University College Hospital","ror":"https://ror.org/00wrevg56","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1289784979","https://openalex.org/I1340918713"]},{"id":"https://openalex.org/I1340918713","display_name":"University College London Hospitals NHS Foundation Trust","ror":"https://ror.org/042fqyp44","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713"]},{"id":"https://openalex.org/I51216347","display_name":"Anglia Ruskin University","ror":"https://ror.org/0009t4v78","country_code":"GB","type":"education","lineage":["https://openalex.org/I51216347"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David J Ralph","raw_affiliation_strings":["Anglia Ruskin University , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","Fibrosis Research Group , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","Urology Department, University College London Hospital , London W1G 8PH , United Kingdom","Fibrosis Research Group, Medical Technology Research Centre, Anglia Ruskin University, Chelmsford CM1 1SQ, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anglia Ruskin University , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","institution_ids":["https://openalex.org/I51216347"]},{"raw_affiliation_string":"Fibrosis Research Group , Medical Technology Research Centre, , Chelmsford CM1 1SQ , United Kingdom","institution_ids":[]},{"raw_affiliation_string":"Urology Department, University College London Hospital , London W1G 8PH , United Kingdom","institution_ids":["https://openalex.org/I1289784979","https://openalex.org/I1340918713"]},{"raw_affiliation_string":"Fibrosis Research Group, Medical Technology Research Centre, Anglia Ruskin University, Chelmsford CM1 1SQ, United Kingdom","institution_ids":["https://openalex.org/I51216347"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5017136849"],"corresponding_institution_ids":["https://openalex.org/I51216347"],"apc_list":{"value":3250,"currency":"USD","value_usd":3250},"apc_paid":null,"fwci":1.458,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.79300372,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"20","issue":"8","first_page":"1057","last_page":"1059"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10459","display_name":"Sexual function and dysfunction studies","score":0.49540001153945923,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10459","display_name":"Sexual function and dysfunction studies","score":0.49540001153945923,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13313","display_name":"Dupuytren's Contracture and Treatments","score":0.41019999980926514,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11815","display_name":"Urological Disorders and Treatments","score":0.07970000058412552,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peyronie-s-disease","display_name":"Peyronie's disease","score":0.996999979019165},{"id":"https://openalex.org/keywords/phosphodiesterase-5-inhibitors","display_name":"phosphodiesterase-5 inhibitors","score":0.9359999895095825},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.9959999918937683},{"id":"https://openalex.org/keywords/myofibroblast-transformation","display_name":"myofibroblast transformation","score":0.7450000047683716},{"id":"https://openalex.org/keywords/tgf-beta1","display_name":"TGF-\u03b21","score":0.8259999752044678},{"id":"https://openalex.org/keywords/extracellular-matrix-deposition","display_name":"extracellular matrix deposition","score":0.7139999866485596},{"id":"https://openalex.org/keywords/penile-curvature","display_name":"penile curvature","score":0.8309999704360962},{"id":"https://openalex.org/keywords/erectile-dysfunction","display_name":"erectile dysfunction","score":0.8199999928474426},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.62776780128479},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.43037763237953186},{"id":"https://openalex.org/C161191863","wikidata":"https://www.wikidata.org/wiki/Q199655","display_name":"Library science","level":1,"score":0.39833468198776245},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.281333327293396},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.08527359366416931},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000068581","descriptor_name":"Tadalafil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068677","descriptor_name":"Sildenafil Citrate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069058","descriptor_name":"Vardenafil Dihydrochloride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010411","descriptor_name":"Penile Induration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D058986","descriptor_name":"Phosphodiesterase 5 Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D058986","descriptor_name":"Phosphodiesterase 5 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1093/jsxmed/qdad083","doi":"https://doi.org/10.1093/jsxmed/qdad083","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jsxmed/qdad083","pdf_url":null,"source":{"id":"https://openalex.org/S159512450","display_name":"The Journal of Sexual Medicine","issn_l":"1743-6095","issn":["1743-6095","1743-6109"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Sexual Medicine","raw_type":"journal-article"},{"id":"pmid:37524687","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37524687","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The journal of sexual medicine","raw_type":"Journal Article"},{"id":"pmh:oai:arro.anglia.ac.uk:708511","doi":null,"is_oa":false,"landing_page_url":"https://arro.anglia.ac.uk/id/eprint/708511/1/EXPERT%20OPINION%20JSM%20Cellek%20et%20al%20v2.2%20CLEAR.docx","pdf_url":null,"source":{"id":"https://openalex.org/S4306402145","display_name":"Anglia Ruskin Research Online (Anglia Ruskin University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I51216347","host_organization_name":"Anglia Ruskin University","host_organization_lineage":["https://openalex.org/I51216347"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/23770275","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Expert_Opinion_A_combination_of_phosphodiesterase_type_5_inhibitor_and_tamoxifen_for_acute_Peyronie_s_disease_the_first_clinical_signals/23770275","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:figshare.com:article/23921904","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/A_combination_of_phosphodiesterase_type_5_inhibitor_and_tamoxifen_for_acute_Peyronie_s_disease_the_first_clinical_signals/23921904","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/23770275","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Expert_Opinion_A_combination_of_phosphodiesterase_type_5_inhibitor_and_tamoxifen_for_acute_Peyronie_s_disease_the_first_clinical_signals/23770275","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1502525967","https://openalex.org/W1541254912","https://openalex.org/W2042270638","https://openalex.org/W2068127169","https://openalex.org/W2086292474","https://openalex.org/W2093416901","https://openalex.org/W2124991789","https://openalex.org/W2325732476","https://openalex.org/W2346758169","https://openalex.org/W2556747551","https://openalex.org/W2895852226","https://openalex.org/W2933207275","https://openalex.org/W3003506753","https://openalex.org/W3038962932","https://openalex.org/W3047571782","https://openalex.org/W3199617203","https://openalex.org/W4214950481","https://openalex.org/W4283781552","https://openalex.org/W4307657756","https://openalex.org/W4309687115","https://openalex.org/W4311180716","https://openalex.org/W4311387226","https://openalex.org/W4319039586","https://openalex.org/W4319308458"],"related_works":["https://openalex.org/W7047996067","https://openalex.org/W7161169566","https://openalex.org/W7163579166","https://openalex.org/W7141451707","https://openalex.org/W2895852226","https://openalex.org/W7001320895","https://openalex.org/W2042270638","https://openalex.org/W2027249644","https://openalex.org/W4383550496","https://openalex.org/W3047571782"],"abstract_inverted_index":{"Peyronie\u2019s":[0],"disease":[1],"(PD)":[2],"is":[3,88,156],"a":[4,160],"fibrotic":[5,162],"disorder":[6],"of":[7,50,83,106,117,134,148,169,178],"the":[8,53,57,80,104,167,173],"penile":[9,22,27,170],"tunica":[10],"albuginea":[11],"(TA)":[12],"and":[13,26,34,38,56,76,146,172,176],"can":[14],"lead":[15],"to":[16,45,48,62,98,126,132,137],"pain":[17],"during":[18],"erection":[19],"and/or":[20,29],"intercourse,":[21],"curvature,":[23],"erectile":[24,77],"dysfunction,":[25],"deformity":[28],"shortening,":[30],"with":[31,64],"psychosocial":[32],"consequences":[33],"impact":[35],"on":[36],"patients":[37],"their":[39],"partners.":[40],"PD":[41,84],"has":[42,59],"been":[43,60],"reported":[44,61],"affect":[46],"0.3%":[47],"13.1%":[49],"men":[51],"in":[52,100],"general":[54],"population,":[55],"prevalence":[58],"increase":[63],"age,":[65],"diabetes,":[66],"hypertension,":[67],"hyperlipidemia,":[68],"Dupuytren\u2019s":[69],"contracture,":[70],"smoking,":[71],"alcohol":[72],"consumption,":[73],"postradical":[74],"prostatectomy,":[75],"dysfunction.1":[78],"While":[79],"exact":[81],"pathophysiology":[82],"remains":[85],"unclear,":[86],"it":[87],"believed":[89],"that":[90,164],"microvascular":[91],"trauma,":[92,96],"or":[93],"repetitive":[94],"minor":[95],"leads":[97,131],"inflammation":[99],"TA,":[101],"which":[102,155],"triggers":[103],"release":[105],"profibrotic":[107,138],"cytokines":[108],"such":[109,152],"as":[110,153],"transforming":[111,118],"growth":[112,119],"factor":[113,120],"\u03b21.":[114],"Increased":[115],"concentrations":[116],"\u03b21":[121],"for":[122,143],"prolonged":[123],"periods":[124],"due":[125],"unresolved":[127],"wound":[128],"healing":[129],"ultimately":[130],"transformation":[133],"resident":[135],"fibroblasts":[136],"myofibroblasts.":[139],"Myofibroblasts":[140],"are":[141],"responsible":[142],"excessive":[144],"production":[145],"deposition":[147],"extracellular":[149],"matrix":[150],"proteins":[151],"collagen,":[154],"then":[157],"remodeled":[158],"into":[159],"dense":[161],"plaque":[163],"may":[165],"cause":[166],"onset":[168],"curvature":[171],"related":[174],"signs":[175],"symptoms":[177],"PD.2":[179]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2023-08-02T00:00:00"}